Last updated on February 2020

MitraClip EXPAND G4 Study

Brief description of study

This primary objective of the EXPAND G4 study is to confirm the safety and performance of the MitraClip G4 System in a post-market setting.

Detailed Study Description

This is a post-market, multi-center, single-arm, prospective study to assess the safety and performance of the next generation MitraClip G4 System. The current protocol describes the design of this post-market study.

Up to 100 post-market, consecutive, consented, patients treated with a MitraClip G4 device will be included for analysis into the MitraClip EXPAND G4 study. Clinical follow-up visits for this study is at 30 days. Cardiovascular adverse events will be reported through 30 days to confirm safety of the MitraClip G4 System.

Clinical Study Identifier: NCT04177394

Find a site near you

Start Over

Cedars-Sinai Medical Center

Los Angeles, CA United States
  Connect »